Company: SCLXW
Filing Date: 2025-12-16
Form Type: S-1
Source: 0001193125-25-319720
Chunk: 627

Company: Scilex Holding Co
Filing Date: 2025-12-16
Form: S-1
Chunk 627
---
 |     |                          |    |
| Outstanding as of September 30, 2025                 |     |         | 1,001 |   |     | $                              | 139.20 |     |                                                    | 5.6 |     | $                        | 65 |
| Vested and expected to vest as of September 30, 2025 |     |         | 1,001 |   |     | $                              | 139.20 |     |                                                    | 5.6 |     | $                        | 65 |
| Exercisable as of September 30, 2025                 |     |         |   812 |   |     | $                              | 124.95 |     |                                                    | 5.1 |     | $                        | 51 |

**Intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of the Common Stock for the options that had exercise prices that were lower than the per share fair value of the Common Stock as of the measurement date of the intrinsic value. The weighted-average grant date fair value per share of stock options were granted during the nine months ended September 30, 2025 was $ 12.94per share. No options were exercised during the nine months ended September 30, 2025. The maximum term of options granted under each of the equity incentive plans is ten years.

Total stock-based compensation recorded within operating expenses was $ 3.3 million and $ 3.7 million for the three months ended September 30, 2025 and 2024, respectively and $ 9.8million and $ 10.9million for the nine months ended September 30, 2025 and 2024, respectively.

The total unrecognized compensation costs related to unvested employee and non-employee stock option grants as of September 30 , 2025 were $ 17.2 million, which the Company expects to recognize over a weighted-average period of approximately 1.6 years.

Scilex Holding Company 2022 Employee Stock Purchase Plan

In October 2022, the Board adopted the Scilex Holding Company 2022 Employee Stock Purchase Plan (the “ESPP”). The purchase price of the Common Stock is equal to 85 % of the lesser of the market value of such shares at the beginning of an offering period or the date of purchase. As of September 30 , 2025, the total number of shares of Common Stock that